Sanofi | SNY - 销售和管理费用

金融业

EUR

EUR 126.81B

现金及等价物

EUR 7.66B

EUR 3.76B

EUR 30.95B

EUR 28.35B

EUR 21.76B

股息收益率

EUR 4.65

EUR 3.74B

EUR 5.66B

EUR 91.57K

EPS每股收益

EUR 2.17

股本和储备

EUR 71.71B

EUR 8.45B

债务利息支出

EUR -25M

EUR 114M

EUR 15.72B

EUR 110.19B

EUR -801M

EUR 10.71B

EUR 1.5B

普通股股本

EUR 1.22B

15.75

EUR -1.16B

EUR 12.14B

销售和管理费用

EUR 2.75B

EUR 22.69B

贸易债权人

EUR 22.93B

应收帐款人

EUR 397M

	销售和管理费用	更改		日
AbbVie	USD 3.58B		316M	2026-03
Amgen	USD 1.58B		354M	2026-03
AstraZeneca	USD 5.06B		455M	2026-03
Bristol-Myers Squibb	USD 1.62B		564M	2026-03
Canopy Growth	CAD 28.9M		636K	2025-12
Corcept Therapeutics	USD 128.04M		13.3M	2026-03
Drreddys Laboratories	INR 26.92B		3.74B	2025-12
Eli Lilly	USD 2.93B		198M	2026-03
Galapagos	EUR 35.5M		8.91M	2026-03
Genmab	DKK 208M		60M	2025-12
GlaxoSmithKline	GBP 2.12B		558M	2026-03
Glaxosmithkline	GBP 3.56B		650.29M	2025-12
J&J	USD 6.03B		719M	2026-03
Merck	USD 2.67B		180M	2026-03
Novartis	USD 3.14B		296M	2026-03
Novartis	USD 3.44B		132M	2025-12
Pacira	USD 83.88M		7.99M	2026-03
Perrigo	USD 267.3M		11.4M	2026-03
Pfizer	USD 2.92B		1.16B	2026-03
Phibro Animal Health	USD 78.32M		10.24M	2025-12
Prestige Brands	USD 29.67M		1.64M	2025-12
Roche Holding	CHF 7.28B		3.99B	2025-12
Sanofi	EUR 2.33B		419M	2026-03
Sanofi	EUR 2.75B		455M	2025-12
Supernus Pharmaceuticals	USD 118.23M		4.16M	2026-03
UCB	EUR 1.47B		193M	2025-12
Zoetis	USD 588M		31M	2026-03